Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus to enhance nerve regeneration after peripheral nerve repair
2005-003409-98Phase 2Completed
- Sponsor
- Erasmus Hospital
- Start
- Dec 2005
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tacrolimus in peripheral nerve injury (PNI), sponsored by Erasmus Hospital. Primary endpoint: Speed and quality of nerve regeneration. Started Dec 2005; status: completed.
02
Drugs
tacrolimus
03
Conditions
peripheral nerve injury (PNI)
Beyond the preview
Go deeper on 2005-003409-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003409-98.